Athira Pharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Athira Pharma and other ETFs, options, and stocks.

About ATHA

Athira Pharma, Inc. engages in the development of small molecules to restore neuronal health and stop neurodegeneration. Its product pipeline includes ATH-1017, ATH-1019/20, and ATH-1018. 

CEO
Mark J. Litton
CEOMark J. Litton
Employees
26
Employees26
Headquarters
Bothell, Washington
HeadquartersBothell, Washington
Founded
2011
Founded2011
Employees
26
Employees26

ATHA Key Statistics

Market cap
16.70M
Market cap16.70M
Price-Earnings ratio
-0.21
Price-Earnings ratio-0.21
Dividend yield
—
Dividend yield—
Average volume
329.24K
Average volume329.24K
High today
$0.445
High today$0.445
Low today
$0.41
Low today$0.41
Open price
$0.4404
Open price$0.4404
Volume
270.74K
Volume270.74K
52 Week high
$3.67
52 Week high$3.67
52 Week low
$0.2195
52 Week low$0.2195

People also own

Based on the portfolios of people who own ATHA. This list is generated using Robinhood data, and it’s not a recommendation.
Tilray Brands
SNDL
Plug Power
Lucid Group
Workhorse
AMC Entertainment
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.